Global Transdermal Therapeutic Systems (TTS) Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Transdermal Therapeutic Systems (TTS) Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Transdermal Therapeutic Systems (TTS) is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.
Transdermal Therapeutic Systems (TTS) report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Transdermal Therapeutic Systems (TTS) market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from OTC Channel and Retail Channel are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Transdermal Therapeutic Systems (TTS) industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Transdermal Therapeutic Systems (TTS) key manufacturers include Hisamitsu, Mylan, GSK, Novartis, Teve (Actavis), Nitto Denko, Johnson & Johnson, Lohmann and Teikoku Seiyaku, etc. Hisamitsu, Mylan, GSK are top 3 players and held % sales share in total in 2022.
Transdermal Therapeutic Systems (TTS) can be divided into Methyl Salicylate, Nitroglycerin, Fentanyl and Nicotine, etc. Methyl Salicylate is the mainstream product in the market, accounting for % sales share globally in 2022.
Transdermal Therapeutic Systems (TTS) is widely used in various fields, such as OTC Channel, Retail Channel and E-Commerce Channel,, etc. OTC Channel provides greatest supports to the Transdermal Therapeutic Systems (TTS) industry development. In 2022, global % sales of Transdermal Therapeutic Systems (TTS) went into OTC Channel filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Transdermal Therapeutic Systems (TTS) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Hisamitsu
Mylan
GSK
Novartis
Teve (Actavis)
Nitto Denko
Johnson & Johnson
Lohmann
Teikoku Seiyaku
Pfizer
Bayer
Lingrui
Sanofi
UCB Pharma
Dr. Reddy's Laboratories
Qizheng
Endo
Mundipharma
Huarun 999
Haw Par
Nichiban
Mentholatum Company
Laboratoires Genevrier
Beijing Tide Pharmaceutical
Luye Pharma Group
Segment by Type
Methyl Salicylate
Nitroglycerin
Fentanyl
Nicotine
Rivastigmine
Estradiol
Others
OTC Channel
Retail Channel
E-Commerce Channel
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Transdermal Therapeutic Systems (TTS) market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Transdermal Therapeutic Systems (TTS), product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Transdermal Therapeutic Systems (TTS) industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Transdermal Therapeutic Systems (TTS) in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Transdermal Therapeutic Systems (TTS) introduction, etc. Transdermal Therapeutic Systems (TTS) Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Transdermal Therapeutic Systems (TTS) market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Transdermal Therapeutic Systems (TTS) report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Transdermal Therapeutic Systems (TTS) market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from OTC Channel and Retail Channel are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Transdermal Therapeutic Systems (TTS) industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Transdermal Therapeutic Systems (TTS) key manufacturers include Hisamitsu, Mylan, GSK, Novartis, Teve (Actavis), Nitto Denko, Johnson & Johnson, Lohmann and Teikoku Seiyaku, etc. Hisamitsu, Mylan, GSK are top 3 players and held % sales share in total in 2022.
Transdermal Therapeutic Systems (TTS) can be divided into Methyl Salicylate, Nitroglycerin, Fentanyl and Nicotine, etc. Methyl Salicylate is the mainstream product in the market, accounting for % sales share globally in 2022.
Transdermal Therapeutic Systems (TTS) is widely used in various fields, such as OTC Channel, Retail Channel and E-Commerce Channel,, etc. OTC Channel provides greatest supports to the Transdermal Therapeutic Systems (TTS) industry development. In 2022, global % sales of Transdermal Therapeutic Systems (TTS) went into OTC Channel filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Transdermal Therapeutic Systems (TTS) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Hisamitsu
Mylan
GSK
Novartis
Teve (Actavis)
Nitto Denko
Johnson & Johnson
Lohmann
Teikoku Seiyaku
Pfizer
Bayer
Lingrui
Sanofi
UCB Pharma
Dr. Reddy's Laboratories
Qizheng
Endo
Mundipharma
Huarun 999
Haw Par
Nichiban
Mentholatum Company
Laboratoires Genevrier
Beijing Tide Pharmaceutical
Luye Pharma Group
Segment by Type
Methyl Salicylate
Nitroglycerin
Fentanyl
Nicotine
Rivastigmine
Estradiol
Others
Segment by Application
OTC Channel
Retail Channel
E-Commerce Channel
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Transdermal Therapeutic Systems (TTS) market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Transdermal Therapeutic Systems (TTS), product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Transdermal Therapeutic Systems (TTS) industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Transdermal Therapeutic Systems (TTS) in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Transdermal Therapeutic Systems (TTS) introduction, etc. Transdermal Therapeutic Systems (TTS) Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Transdermal Therapeutic Systems (TTS) market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices